[HTML][HTML] A roadmap towards a human-centric safety assessment of advanced therapy medicinal products
HT Chien, VC de Leeuw, JCJ van Esterik… - Regulatory Toxicology …, 2024 - Elsevier
… Advanced therapy medicinal products (ATMPs) are among the most complex pharmaceuticals
with high human specificity. Species differences severely limit the clinical relevance of in …
with high human specificity. Species differences severely limit the clinical relevance of in …
Regulatory aspects for approval of advanced therapy medicinal products in the EU
S Fürst-Ladani, A Bührer, W Fürst… - Drug Delivery and …, 2023 - Springer
… Advanced therapy medicinal products (ATMPs) are a group of … biological medicines that
offer novel therapeutic opportunities … therapy medicinal products (GTMPs), somatic cell therapy …
offer novel therapeutic opportunities … therapy medicinal products (GTMPs), somatic cell therapy …
The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the WHO Global Benchmarking Tool standards
… Advanced therapy medicinal products (ATMPs) are rapidly evolving to offer new treatment
options. The scientific, technical and clinical complexities subject drug … technology evaluation …
options. The scientific, technical and clinical complexities subject drug … technology evaluation …
[HTML][HTML] Real world data in health technology assessment of complex health technologies
MA Hogervorst, J Pontén, RA Vreman… - Frontiers in …, 2022 - frontiersin.org
… Novel, complex treatment strategies such as health technologies with concomitant genetic
testing, advanced therapy medicinal products (ATMPs) or the assessment of sequences of …
testing, advanced therapy medicinal products (ATMPs) or the assessment of sequences of …
… pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and …
Full article: An accelerated access pathway for innovative high-risk medical devices under
the new European Union Medical Devices and health technology assessment regulations? …
the new European Union Medical Devices and health technology assessment regulations? …
[PDF][PDF] Commercialisation of Advanced Therapies
J Mansnérus - … Regulation on Advanced Therapy Medical Products …, 2016 - helda.helsinki.fi
… , improve safety and access to advanced therapies include: facilitating R&D by adaptive,
risk… , regulatory authorities as well as health technology assessment bodies and payers alike. …
risk… , regulatory authorities as well as health technology assessment bodies and payers alike. …
Regulating advanced therapy medicinal products through the Hospital Exemption: an analysis of regulatory approaches in nine EU countries
DGM Coppens, H Gardarsdottir, MLD Bruin… - … Medicine, 2020 - Taylor & Francis
… The Hospital Exemption (HE) was enacted to accommodate manufacturing of advanced
therapy medicinal products (ATMPs) for treatment purposes. However, how its implementation …
therapy medicinal products (ATMPs) for treatment purposes. However, how its implementation …
[HTML][HTML] Surrogate endpoints in health technology assessment: an international review of methodological guidelines
B Grigore, O Ciani, F Dams, C Federici, S de Groot… - …, 2020 - Springer
… health technologies Our survey shows that many international health technology assessment
(HTA) agencies currently lack detailed guidance for the evaluation of health technologies …
(HTA) agencies currently lack detailed guidance for the evaluation of health technologies …
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
M Pochopień, E Paterak, E Clay, J Janik… - … Market Access & Health …, 2021 - mdpi.com
… therapies are a novel treatment approach, they may be assessed by health technology
assessment (… A standardised approach to gene therapies has not been elaborated yet. Moreover, …
assessment (… A standardised approach to gene therapies has not been elaborated yet. Moreover, …
[HTML][HTML] Promoting innovation while controlling cost: the UK's approach to health technology assessment
… ’ technologies such as advanced therapy medicinal products (ATMPs), defined as “medicines
for … Emerging developments in immunotherapy in cancer and gene therapy, will lead to an …
for … Emerging developments in immunotherapy in cancer and gene therapy, will lead to an …